Recent Patents on Anti-Cancer Drug Discovery
短名 | PRA |
Journal Impact | 2.46 |
国际分区 | PHARMACOLOGY & PHARMACY(Q3) |
期刊索引 | SCI Q3中科院 4 区 |
ISSN | 1574-8928, 2212-3970 |
h-index | 52 |
国内分区 | 医学(4区)医学肿瘤学(4区)医学药学(4区) |
AIMS & SCOPERECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY 发表评论和研究文章,反映或处理与专利相关的研究、报告专利在研究中的应用、对给定专利申请结果比较的讨论等,并客座编辑了有关抗癌药物发现领域最新专利的主题问题,例如。关于新型生物活性化合物、类似物、靶标和预测性生物标志物和药物疗效生物标志物。该杂志还出版电子书和抗癌药物发现书籍的书评。该期刊还收录了一系列重要的和最近的抗癌药物发现专利。该杂志是所有参与抗癌药物设计和发现的研究人员的必备读物。该杂志还涵盖了与抗癌药物发现相关的快速新兴治疗领域/靶点和治疗剂的最新研究(已注册专利)。
期刊主页投稿网址涉及主题 | 生物医学遗传学内科学化学生物化学癌症癌症研究基因药理学有机化学病理计算机科学物理细胞生物学免疫学 |
出版信息 | 出版商: Bentham Science Publishers B.V.,出版周期: Tri-annual,期刊类型: journal |
基本数据 | 创刊年份: 2006,原创研究文献占比: 41.18%,自引率:4.00%, Gold OA占比: 0.00% |
平均审稿周期 | 网友分享经验:平均3.0个月 |
平均录用比例 | 网友分享经验:较易 |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Patent Selections
2024-12-1
Integrating Bioinformatics and Drug Sensitivity Analyses to Identify Molecular Characteristics Associated with Targeting Necroptosis in Breast Cancer and their Clinical Prognostic Significance
2024-12-1
TGF-β score based on silico analysis can robustly predict prognosis and immunological characteristics in lower-grade glioma: the evidence from multicenter studies
2024-12-1
Targeted Regulation of Osteoblasts and Osteoclasts in Osteosarcoma Patients by CSF3R Receptor Inhibition of Osteolysis Caused by Tumor Inflammation Based on Transcriptional Spectrum Analysis and Drug Library Screening
2024-12-1
CK2B is a Prognostic Biomarker and a Potential Drug Target for Hepatocellular Carcinoma
2024-12-1
Identification of the Roles of Coagulation-Related Signature and its Key Factor RABIF in Hepatoma Cell Malignancy
2024-12-1
Fatty Acid Metabolism Signature Contributes to the Molecular Diagnosis of a Malignant Gastric Cancer Subtype with Poor Prognosis and Lower Mutation Burden
2024-12-1
Upregulation of M6A Reader HNRNPA2B1 Associated with Poor Prognosis and Tumor Progression in Lung Adenocarcinoma
2024-12-1
Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies
2024-12-1
Comprehensive Genomic Analysis of Puerarin in Inhibiting Bladder Urothelial Carcinoma Cell Proliferation and Migration
2024-9-1
Co-delivery of siAPE1 and melatonin by 125I-loaded PSMA-targeted nanoparticles for the treatment of prostate cancer
2024-9-1
Characterization of the Prognosis and Tumor Microenvironment of Cellular Senescence-related Genes through scRNA-seq and Bulk RNA-seq Analysis in GC
2024-9-1
The m6A Reader IGF2BP2 Promotes Oral Squamous Cell Carcinoma Progression by Maintaining UCA1 Stability
2024-8-26
Comprehensive Analysis and Experimental Validation of TLL2 as a Potential New Prognostic Biomarker Associated with Immune Infiltration in Lung Adenocarcinoma
2024-8-26
Phosphofructokinase-1 in Cancer: A Promising Target for Diagnosis and Therapy
2024-8-21
Ligustilide Inhibits the PI3K/AKT Signalling Pathway and Suppresses Cholangiocarcinoma Cell Proliferation, Migration, and Invasion
2024-8-20
Ruthenium Complex Suppresses Proliferation of Residual Hepatocellular Carcinoma after Incomplete Radiofrequency Ablation Therapy
2024-8-12
Chebulinic Acid: An Incipient Anticancer Agent
2024-8-1
A Patent Review of Human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors as Anticancer Agents and their Other Therapeutic Applications (1999-2022)
2024-8-1
LncRNA FAM83H-AS1 Contributes to the Radio-resistance and Proliferation in Liver Cancer through Stability FAM83H Protein
2024-8-1
Competitive Effect of Overexpressed C-terminal of Snail-1 (CSnail) in Control of the Growth and Metastasis of Melanoma Cells
2024-8-1
Integrated Single-cell and Bulk RNA Sequencing Analysis Cross Talk between Ferroptosis-related Genes and Prognosis in Oral Cavity Squamous Cell Carcinoma
2024-8-1
1,3,4-Oxadiazoles as Anticancer Agents: A Review
2024-8-1
Adverse Effects of Gefitinib on Skin and Colon in a Lung Cancer Mouse Model
2024-8-1
PSMA PET/MR is a New Imaging Option for Identifying Glioma Recurrence and Predicting Prognosis
2024-8-1
Predictive Modelling of Overall Survival in Adult Patients with Primary Diffuse Large B-cell Lymphoma of the Breast Using the Surveillance, Epidemiology, and End Results (SEER) Database
2024-8-1
KRAS Pathways: A Potential Gateway for Cancer Therapeutics and Diagnostics
2024-8-1
Prognostic Value of Fatty Acid Metabolism-related Genes in Patients with Bladder Cancer
2024-8-1
From Multiple Myeloma to Acute Myeloid Leukemia: A Case Report of a 61-year-old Woman after 8 Years of Chemotherapy and Immunotherapy
2024-8-1
Patent Selections
2024-8-1
Identification of Immune Infiltration-related Molecular Features in Ovarian Cancer Patients and Experimental Validation of Immune Response Molecular Mechanisms through Integrated WGCNA, Machine Learning, and Single-cell Sequencing Analysis
2024-7-18
Epigallocatechin Gallate Derivative Y6 Reverses Oxaliplatin Resistance in Hepatocellular Carcinoma via Targeting the MiR-338-3p/HIF-1α/TWIST Axis to Inhibit EMT
2024-7-11
Tyrosine Kinase Inhibitor Lenvatinib Causes Cardiotoxicity by Inducing Endoplasmic Reticulum Stress and Apoptosis through Activating ATF6, IRE1α and PERK Signaling Pathways
2024-7-11
Fumarate-1 Mediates the Regulation of Mitochondrial Homeostasis by PGC-1α to Promote Cell Pyroptosis and Inhibit the Progression of Thyroid Cancer
2024-7-11
Radiotherapy Enhancing and Radioprotective Properties of Berberine: A Systematic Review
2024-7-9
Adhesin Component Member STAG2 Enhances Cisplatin Tolerance in Colorectal Cancer Cells through the Epithelial-Mesenchymal Transition Pathway
2024-7-3
The Synergistic Anti-tumor Effects of Evodiamine based on Animal Model Experiments: A Systematic Review and Meta-analysis
2024-7-2
Preclinical Effects Of Melatonin On The Development Of Ehrlich's Tumor: A Biochemical, Cognitive, And Molecular Approach
2024-6-21
Patents on PARP-1 Inhibitors for the Management of Cancer from 2017-2023
2024-6-13
Acknowledgements to Reviewers
2024-6-5
Patent Selections
2024-6-5
Regulation of Metastasis and Growth of Colorectal Cancer via Targeting the PTEN Pathway: An Update on the Progress of LncRNA MLLT4-AS1
2024-6-3
Construction and Identification of a Human Colorectal Adenoma Epithelial Cell Line by SV40 Large T-Antigen Transfection
2024-5-28
PDLIM1 Inhibits Chemoresistance by Blocking DNA Damage Repair in Gastric Cancer
2024-5-22
Development of a Prognostic Risk Model Based on Oxidative StressRelated Genes for Platinum-Resistant Ovarian Cancer Patients
2024-5-9
Structure-Based Virtual Screening Identifying Novel FOXM1 Inhibitors as the Lead Compounds for Glioblastoma
2024-5-9
Stem Cell Markers in Neoplasms and their Relationship with Progression-free and Overall Survival in Patients with Recurrence
2024-5-9
USP31 Activates the Wnt/β-catenin Signaling Pathway and Promotes Gastric Cancer Cell Proliferation, Invasion and Migration
2024-5-7
Development and Evaluation of a Novel Hyaluronic Acid and Chitosan-modified Phytosome for Co-delivery of Oxymatrine and Glycyrrhizin for Combination Therapy
2024-5-1
YBX1, Targeted By Microrna-382-5p, Promotes Laryngeal Squamous Cell Carcinoma Progression via Modulating RAS/MAPK Signaling
2024-5-1
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远